|
8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- Suppliers list
|
|
| | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- Basic information |
| Product Name: | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- | | Synonyms: | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- | | CAS: | 2692624-30-7 | | MF: | C20H32O2 | | MW: | 304.47 | | EINECS: | | | Product Categories: | | | Mol File: | 2692624-30-7.mol |  |
| | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- Chemical Properties |
| solubility | 0.1 M Na2CO3: 1.7 mg/ml
DMF: >100 mg/ml
DMSO: >100 mg/ml
Ethanol: Miscible |
| | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- Usage And Synthesis |
| Uses | ω-3 Arachidonic Acid-d8 is the deuterium labeled ω-3 Arachidonic Acid[1]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] E J NEUFELD. Fatty acid structural requirements for activity of arachidonoyl-CoA synthetase.[J]. Journal of Lipid Research, 1984, 25 3: 288-293.
[3] AP S. Omega-3 fatty acids in health and disease and in growth and development[J]. American Journal of Clinical Nutrition, 1991, 54 3: Pages 438-463. DOI: 10.1093/ajcn/54.3.438 |
| | 8,11,14,17-Eicosatetraenoic-8,9,11,12,14,15,17,18-d8 acid, (8Z,11Z,14Z,17Z)- Preparation Products And Raw materials |
|